BiopharmX's IPO

BiopharmX raised a round of funding on June 08, 2015. Investors include Public.

BioPharmX (NYSEAMERICAN: BPMX) provides drug-delivery products through its unique platform technologies for pharmaceutical and OTC applications. BioPharmX products address unmet needs in large, well-d…

Articles about BiopharmX's IPO: